The number of knee replacements doubled in 16 years, but did recipients’ lives improve as a result? With health expenditure set to outpace GDP growth, collecting data to answer questions like this is crucial

At a Science|Business event in Norway, students, technology experts and teachers debated the merits of new breeds of healthcare delivery. There are benefits, but digital health must be thoughtfully controlled and users properly trained

Time from patent to patient has increased by more than a year, Institute of Cancer Research finds in new study

Spain is widely regarded as having one of the world’s best healthcare systems. Can a series of experiments in ‘value-based’ care help to make it even better? A new Science|Business report finds out

Neil Bacon, an advocate for empowering patients, has become president, CEO of non-profit dedicated to measuring patient outcomes

At the Euroscience Open Forum conference, a Bulgarian medical start-up demonstrates the potential - and the challenges - of getting health systems to focus on preventing disease, rather than responding when it strikes

High consumption rates and the widespread use of broad-spectrum antibiotics is worrying, and ‘Romania is at a cross-roads’ says the European Centre for Disease Prevention and Control.

An app developed by Google’s AI company saves nurses two hours a day. But so far it is free to use. An independent panel says DeepMind must clarify the business model, a stark illustration that as healthcare AI goes mainstream, the matter of who does what with patient data is coming into sharper focus

It is crucial to incorporate patient perspectives on healthcare innovation and decision making to increase the sustainability of Europe’s healthcare systems. A panel held at the Science|Business annual conference looked at the role Horizon Europe can play in achieving this  

Funding science and providing incentives to spur innovation in antibiotics is crucial, but political support for stewardship and prevention of inappropriate use is just as important in ensuring availability of effective and affordable drugs that are used in a responsible way

Patients are getting more access and control over their health records, but for now there are no plans to systematically collect data on outcomes

There’s huge variation around Europe in healthcare. Experts convened by Science|Business over the past two years offer explanations – and solutions